OrthoMend Research acquired from Temple University researchers an exclusive license to develop novel absorbable bone fixation and regenerative repair technologies for commercial use.
OrthoMend will commence manufacture and testing of the NanoDiamond technology, which comprises a suite of fixation and drug delivery devices such as absorbable screws and pins.
Other absorbable materials in 2016 news included:
Abyrx’s resorbable and absorbable hemostatic bone putties
OrthoMend Research acquired from Temple University researchers an exclusive license to develop novel absorbable bone fixation and regenerative repair technologies for commercial use.
OrthoMend will commence manufacture and testing of the NanoDiamond technology, which comprises a suite of fixation and drug delivery devices such as absorbable...
OrthoMend Research acquired from Temple University researchers an exclusive license to develop novel absorbable bone fixation and regenerative repair technologies for commercial use.
OrthoMend will commence manufacture and testing of the NanoDiamond technology, which comprises a suite of fixation and drug delivery devices such as absorbable screws and pins.
Other absorbable materials in 2016 news included:
Abyrx’s resorbable and absorbable hemostatic bone putties
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
